Diagnostic performance of the Kaiser score for contrast-enhanced mammography and magnetic resonance imaging in breast masses: A Comparative Study.

The Kaiser score (KS) is a simple and intuitive machine-learning derived decision rule for characterizing breast lesions in a clinical setting and screening for breast cancer. The present study aims to investigate the applicability of the KS for contrast-enhanced mammography (CEM) in breast masses, and to compare its diagnostic accuracy with magnetic resonance imaging (MRI). CEM may provide an alternative option for patients with breast masses, especially for those with MRI contraindications. Two hundred and seventy-five patients with breast enhanced masses were included in the study from May 2019 to September 2022. Patients were further divided into benign and malignant groups based on pathological diagnosis. The CEM and MRI imaging characteristics of these two groups were analyzed statistically. The paired chi-square and Cohen's kappa coefficient (κ) analysis were used to compare imaging characteristics between CEM and MRI. The Breast Imaging Reporting and Data System (BI-RADS) and KS for CEM and MRI were evaluated based on imaging characteristics. The diagnostic performance of BI-RADS and KS for CEM and MRI was assessed and compared using receiver operating characteristic (ROC) analysis and DeLong's test. The imaging characteristics of root sign, time-signal intensity curve (TIC/mTIC), margin, internal enhancement pattern (IEP), edema, apparent diffusion coefficient (ADC) values, and suspicious malignant microcalcifications showed significant differences between benign and malignant lesions (all p ≤ 0.011). The detection rate of root sign and margin showed substantial agreement between CEM and MRI (κ = 0.656, κ = 0.640), but IEP, TIC/mTIC, and edema showed poor agreement (κ = 0.380, κ = 0.320, κ = 0.324). For all lesion analyses, the area under the curves (AUCs) of the KS (0.897 ∼ 0.932) were higher than that of BI-RADS (0.691) in CEM (all p < 0.001). The AUC of KS (calcification)-CEM (0.932) was higher than those of both KS-CEM and KS (edema)-CEM (0.897 and 0.899) (all p < 0.001). For subgroup analyses, the AUCs of the KS (0.875 ∼ 0.876) were higher than that of BI-RADS (0.740) in MRI (all p < 0.001). The AUCs of KS-MRI (0.876) and KS (ADC)-MRI (0.875) were similar to those of KS-CEM (0.878) and KS (edema)-CEM (0.870) (all p > 0.100). The AUC of KS (calcification)-CEM (0.934) was slightly higher than those of both KS-MRI (0.876) and KS (ADC)-MRI (0.875), but no significant difference was observed (p = 0.051; p = 0.071). The KS for CEM provided high diagnostic accuracy in distinguishing breast masses, comparable to that of MRI. The application of KS (calcification)-CEM combined with suspicious malignant microcalcifications can improve diagnostic efficiency with an AUC of 0.932 ∼ 0.934. However, edema did not significantly improve performance when using the KS for CEM.

Hua B ，Yang G ，Wang Y ，Chen J ，Rong X ，Yuan T ，Quan G ... -  《-》

Breast non-mass enhancement lesions on contrast-enhanced mammography: modified breast image reporting and data system classification.

To investigate the utility of contrast-enhanced mammography (CEM) in the differential diagnosis of breast non-mass enhancement (NME) lesions, and to compare the diagnostic performance of BI-RADS for NME lesions in MG, US, MRI, and CEM. A total of 120 patients were included from April 2019 to April 2022. The independent enhancement descriptors for malignancy of NME were identified through binary logistic regression analysis. The modified BI-RADS in CEM (mBI-RADS (CEM)) was defined after adjusting the BI-RADS (MG) by independent descriptors. The diagnostic performances of BI-RADS in low-energy image, US, MRI, and CEM were evaluated and compared using receiver operating characteristic (ROC) analysis and DeLong's test. The enhancement descriptors of enhancement morphological distribution, internal enhancement pattern and time-signal intensity curve were identified as independent risk factors for malignancy (all P≤0.001). For all-group NME analyses, the areas under the curve (AUCs) of mBI-RADS (CEM) were higher than those of BI-RADS (MG) (all P<0.050). For sub-group NME analyses, the AUCs of mBI-RADS (CEM) and BI-RADS (MRI) were higher than those of BI-RADS (MG) and BI-RADS (US) (all P<0.001). While in NME with non-micro-calcification sub-group, the area under the receiver operating characteristics curve of mBI-RADS (CEM) was higher than those of BI-RADS (MRI), both of which were higher than those of BI-RADS (MG) and BI-RADS (US) (all P<0.050). The mBI-RADS (CEM), which integrates morphological and enhancement features, can significantly improve the diagnostic accuracy compared with BI-RADS (MG). Furthermore, the mBI-RADS (CEM) demonstrated specific advantages for NME with micro-calcifications compared with BI-RADS (MRI).

Hua B ，Chen J ，Li QR ，Ge JD ，Yuan T ，Quan GM ... -  《-》

Clinical and Imaging Characteristics of Contrast-enhanced Mammography and MRI to Distinguish Microinvasive Carcinoma from Ductal Carcinoma In situ.

Hua B ，Yang G ，An Y ，Lou K ，Chen J ，Quan G ，Yuan T ... -  《-》

Breast lesions on MRI in mass and non-mass enhancement: Kaiser score and modified Kaiser score + for readers of variable experience.

To compare the diagnostic performance of three readers using BI-RADS and Kaiser score (KS) based on mass and non-mass enhancement (NME) lesions. A total of 630 lesions, 393 malignant and 237 benign, 458 mass and 172 NME, were analyzed. Three radiologists with 3 years, 6 years, and 13 years of experience made diagnoses. 596 cases had diffusion-weighted imaging, and the apparent diffusion coefficient (ADC) was measured. For lesions with ADC > 1.4 × 10-3 mm2/s, the KS was reduced by 4 as the modified KS +, and the benefit was assessed. When using BI-RADS, AUC was 0.878, 0.915, and 0.941 for mass, and 0.771, 0.838, 0.902 for NME for Reader-1, 2, and 3, respectively, better for mass than for NME. The diagnostic accuracy of KS was improved compared to BI-RADS for less experienced readers. For Reader-1, AUC was increased from 0.878 to 0.916 for mass (p = 0.005) and from 0.771 to 0.822 for NME (p = 0.124). Based on the cut-off value of BI-RADS ≥ 4B and KS ≥ 5 as malignant, the sensitivity of KS by Readers-1 and -2 was significantly higher for both Mass and NME. When ADC was considered to change to modified KS +, the AUC and the accuracy for all three readers were improved, showing higher specificity with slightly degraded sensitivity. The benefit of KS compared to BI-RADS was most noticeable for the less experienced readers in improving sensitivity. Compared to KS, KS + can improve specificity for all three readers. For NME, the KS and KS + criteria need to be further improved. KS provides an intuitive method for diagnosing lesions on breast MRI. BI-RADS and KS face greater difficulties in evaluating NME compared to mass lesions. Adding ADC to the KS can improve specificity with slightly degraded sensitivity. KS provides an intuitive method for interpreting breast lesions on MRI, most helpful for novice readers. KS, compared to BI-RADS, improved sensitivity in both mass and NME groups for less experienced readers. NME lesions were considered during the development of the KS flowchart, but may need to be better defined.

Zhou J ，Liu H ，Miao H ，Ye S ，He Y ，Zhao Y ，Chen Z ，Zhang Y ，Liu YL ，Pan Z ，Su MY ，Wang M ... -  《-》

A nomogram based on multiparametric magnetic resonance imaging improves the diagnostic performance of breast lesions diagnosed as BI-RADS category 4: A comparative study with the Kaiser score.

To construct a nomogram combining Kaiser score (KS), synthetic MRI (syMRI) parameters, apparent diffusion coefficient (ADC), and clinical features to distinguish benign and malignant breast lesions better. From December 2022 to February 2024, a retrospective cohort of 168 patients with breast lesions diagnosed as Breast Imaging Reporting and Data System (BI-RADS) category 4 by ultrasound and/or mammography was included. The research population was divided into the training set (n = 117) and the validation set (n = 51) by random sampling with a ratio of 7:3. Breast lesions' KS, ADC, relaxation time of syMRI, and clinical and imaging features were statistically analyzed and compared between malignant and benign groups. Two experienced radiologists independently assigned KS, and measured quantitative values of ADC and parameters of syMRI, and the intraclass correlation coefficient (ICC) was calculated. Independent predictors were identified by univariable and multivariable logistic regression analysis. Then, a nomogram was established, and its performance was evaluated by the area under the curve (AUC), calibration curve, and decision curve. There were 168 lesions (118 malignant and 50 benign) in 168 female patients confirmed by histopathology. The interobserver agreement for each quantitative parameter was excellent. Older patient (OR = 1.091, 95 % confidence interval [CI]: 1.017-1.170, P = 0.014), higher lesions' KS (OR = 288.431, 95 % CI: 34.930-2381.654, P < 0.001), lower ADC (OR = 0.077, 95 % CI: 0.011-0.558, P = 0.011), and lower T2 relaxation time (OR = 0.918, 95 % CI: 0.868-0.972, P = 0.003) were independent predictors of breast malignancies and utilized to establish the nomogram. The accuracy of KS, ADC, T2, and patient age in predicting malignant breast lesions was 88.89 %, 79.48 %, 82.05 %, and 58.97 %, respectively. No significant differences in AUCs of KS, ADC and T2 were observed in distinguishing benign from malignant breast lesions. The nomogram yielded higher AUCs of 0.968 (0.934-0.996) and 0.959 (0.863-0.995) in training and validation sets than KS, ADC, T2, and patient age (p < 0.05). Although there were no significant differences among the AUCs of KS, ADC, and T2, the constructed nomogram incorporating these parameters significantly improves diagnostic performance for distinguishing benign and malignant BI-RADS 4 breast lesions. Future external validation is needed in practical applications.

Yang X ，Lu Z ，Tan X ，Shao L ，Shi J ，Dou W ，Sun Z ... -  《-》